Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Carol Tacket

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Procedures

Living Beings

Disorders

Anatomy

Feces

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
54
Levine, Myron
42
Losonsky, Genevieve
33
Edelman, Robert
23
Nataro, James
18
Wasserman, Steven
17
Kaper, James
14
Sztein, Marcelo
10
Cryz, Stanley
6
Dougan, Gordon
6
Morris, Glenn
6
Hone, David
6
Kotloff, Karen
5
Chatfield, Steven
4
Eckels, Kenneth
4
Michalski, Jane

Sign-in to see all Coauthors

Publications

TOP 3
Khanna Niharika; Nesbitt Laquandra; Roghmann Mary-Claire; Tacket Carol
Translation of clinical research into practice: defining the clinician scientist.
Tacket C O
Plant-based oral vaccines: results of human trials.
Wahid R; Salerno-Gonçalves R; Tacket C O; Levine M M; Sztein M B
Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Carol Tacket (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Khanna Niharika; Nesbitt Laquandra; Roghmann Mary-Claire; Tacket Carol
Translation of clinical research into practice: defining the clinician scientist.
Family medicine 2009;41(6):440-3.
2009: Tacket C O
Plant-based oral vaccines: results of human trials.
Current topics in microbiology and immunology 2009;332():103-17.
2008: Wahid R; Salerno-Gonçalves R; Tacket C O; Levine M M; Sztein M B
Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans.
Mucosal immunology 2008;1(5):389-98.
2007: Lombardo Mary-Jane; Michalski Jane; Martinez-Wilson Hector; Morin Cara; Hilton Tamara; Osorio Carlos G; Nataro James P; Tacket Carol O; Camilli Andrew; Kaper James B
An in vivo expression technology screen for Vibrio cholerae genes expressed in human volunteers.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(46):18229-34.
2007: Tacket Carol O; Levine Myron M
CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45 Suppl 1():S20-3.
2007: Wahid Rezwanul; Salerno-Gonçalves Rosangela; Tacket Carol O; Levine Myron M; Sztein Marcelo B
Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.
Vaccine 2007;25(8):1416-25.
2007: Tacket Carol O
Plant-based vaccines against diarrheal diseases.
Transactions of the American Clinical and Climatological Association 2007;118():79-87.
2005: Dowling Thomas C; Chavaillaz Pierre A; Young David G; Melton-Celsa Angela; O'Brien Alison; Thuning-Roberson Claire; Edelman Robert; Tacket Carol O
Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteers.
Antimicrobial agents and chemotherapy 2005;49(5):1808-12.
2005: Tacket Carol O
Plant-derived vaccines against diarrheal diseases.
Vaccine 2005;23(15):1866-9.
2004: Tacket Carol O
Garden-variety vaccines: antigens derived from transgenic plants.
Expert review of vaccines 2004;3(5):529-31.
2004: Tacket Carol O; Pasetti Marcela F; Edelman Robert; Howard John A; Streatfield Stephen
Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn.
Vaccine 2004;22(31-32):4385-9.
2004: Tacket Carol O; Pasetti Marcela F; Sztein Marcelo B; Livio Sofie; Levine Myron M
Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
The Journal of infectious diseases 2004;190(3):565-70.
2004: Tacket Carol O
Plant-derived vaccines against diarrhoeal diseases.
Expert opinion on biological therapy 2004;4(5):719-28.
2004: Belshe Robert B; Newman Frances K; Frey Sharon E; Couch Robert B; Treanor John J; Tacket Carol O; Yan Lihan
Dose-dependent neutralizing-antibody responses to vaccinia.
The Journal of infectious diseases 2004;189(3):493-7.
2003: Kanesa-Thasan N; Edelman R; Tacket C O; Wasserman S S; Vaughn D W; Coster T S; Kim-Ahn G J; Dubois D R; Putnak J R; King A; Summers P L; Innis B L; Eckels K H; Hoke C H
Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines.
The American journal of tropical medicine and hygiene 2003;69(6 Suppl):17-23.
2003: Tacket Carol O; Sztein Marcelo B; Losonsky Genevieve A; Wasserman Steven S; Estes Mary K
Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers.
Clinical immunology (Orlando, Fla.) 2003;108(3):241-7.
2003: Salerno-Gonçalves Rosângela; Wyant Timothy L; Pasetti Marcela F; Fernandez-Viña Marcelo; Tacket Carol O; Levine Myron M; Sztein Marcelo B
Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(5):2734-41.
2003: Tacket Carol O
High-risk research in healthy volunteers.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2003;51 Suppl 1():S1.
2002: Frey Sharon E; Couch Robert B; Tacket Carol O; Treanor John J; Wolff Mark; Newman Frances K; Atmar Robert L; Edelman Robert; Nolan Carrie M; Belshe Robert B;
Clinical responses to undiluted and diluted smallpox vaccine.
The New England journal of medicine 2002;346(17):1265-74.
2001: Levine M M; Tacket C O; Sztein M B
Host-Salmonella interaction: human trials.
Microbes and infection / Institut Pasteur 2001;3(14-15):1271-9.
2000: Tacket C O; Galen J; Sztein M B; Losonsky G; Wyant T L; Nataro J; Wasserman S S; Edelman R; Chatfield S; Dougan G; Levine M M
Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.
Clinical immunology (Orlando, Fla.) 2000;97(2):146-53.
2000: Tacket C O; Mason H S; Losonsky G; Estes M K; Levine M M; Arntzen C J
Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes.
The Journal of infectious diseases 2000;182(1):302-5.
2000: Edelman R; Tacket C O; Wasserman S S; Bodison S A; Perry J G; Mangiafico J A
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.
The American journal of tropical medicine and hygiene 2000;62(6):681-5.
2000: Tacket C O; Sztein M B; Losonsky G; Abe A; Finlay B B; McNamara B P; Fantry G T; James S P; Nataro J P; Levine M M; Donnenberg M S
Role of EspB in experimental human enteropathogenic Escherichia coli infection.
Infection and immunity 2000;68(6):3689-95.
2000: Birx D L; Loomis-Price L D; Aronson N; Brundage J; Davis C; Deyton L; Garner R; Gordin F; Henry D; Holloway W; Kerkering T; Luskin-Hawk R; McNeil J; Michael N; Foster Pierce P; Poretz D; Ratto-Kim S; Renzullo P; Ruiz N; Sitz K; Smith G; Tacket C; Thompson M; Tramont E; Yangco B; Yarrish R; Redfield R R
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.
The Journal of infectious diseases 2000;181(3):881-9.
2000: Tacket C O; Sztein M B; Wasserman S S; Losonsky G; Kotloff K L; Wyant T L; Nataro J P; Edelman R; Perry J; Bedford P; Brown D; Chatfield S; Dougan G; Levine M M
Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers.
Infection and immunity 2000;68(3):1196-201.
1999: Tacket C O; Cohen M B; Wasserman S S; Losonsky G; Livio S; Kotloff K; Edelman R; Kaper J B; Cryz S J; Giannella R A; Schiff G; Levine M M
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
Infection and immunity 1999;67(12):6341-5.
1999: Tacket C O; Losonsky G; Livio S; Edelman R; Crabb J; Freedman D
Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal.
The Journal of infectious diseases 1999;180(6):2056-9.
1999: Tacket C O; Mason H S
A review of oral vaccination with transgenic vegetables.
Microbes and infection / Institut Pasteur 1999;1(10):777-83.
1999: Tacket C O; Roy M J; Widera G; Swain W F; Broome S; Edelman R
Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device.
Vaccine 1999;17(22):2826-9.
1999: Taylor D N; Sanchez J L; Castro J M; Lebron C; Parrado C M; Johnson D E; Tacket C O; Losonsky G A; Wasserman S S; Levine M M; Cryz S J
Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama.
Infection and immunity 1999;67(4):2030-4.
1998: Bartlett J A; Wasserman S S; Hicks C B; Dodge R T; Weinhold K J; Tacket C O; Ketter N; Wittek A E; Palker T J; Haynes B F
Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative.
AIDS (London, England) 1998;12(11):1291-300.
1998: Tacket C O; Mason H S; Losonsky G; Clements J D; Levine M M; Arntzen C J
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.
Nature medicine 1998;4(5):607-9.
1998: Sack D A; Tacket C O; Cohen M B; Sack R B; Losonsky G A; Shimko J; Nataro J P; Edelman R; Levine M M; Giannella R A; Schiff G; Lang D
Validation of a volunteer model of cholera with frozen bacteria as the challenge.
Infection and immunity 1998;66(5):1968-72.
1998: Freedman D J; Tacket C O; Delehanty A; Maneval D R; Nataro J; Crabb J H
Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli.
The Journal of infectious diseases 1998;177(3):662-7.
1998: Tacket C O; Taylor R K; Losonsky G; Lim Y; Nataro J P; Kaper J B; Levine M M
Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection.
Infection and immunity 1998;66(2):692-5.
1998: Donnenberg M S; Tacket C O; Losonsky G; Frankel G; Nataro J P; Dougan G; Levine M M
Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge.
Infection and immunity 1998;66(1):52-8.
1997: Taylor D N; Tacket C O; Losonsky G; Castro O; Gutierrez J; Meza R; Nataro J P; Kaper J B; Wasserman S S; Edelman R; Levine M M; Cryz S J
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.
Infection and immunity 1997;65(9):3852-6.
1997: Tacket C O; Kelly S M; Schödel F; Losonsky G; Nataro J P; Edelman R; Levine M M; Curtiss R
Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.
Infection and immunity 1997;65(8):3381-5.
1997: Tacket C O; Kotloff K L; Losonsky G; Nataro J P; Michalski J; Kaper J B; Edelman R; Levine M M
Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111.
The American journal of tropical medicine and hygiene 1997;56(5):533-7.
1997: Losonsky G A; Lim Y; Motamedi P; Comstock L E; Johnson J A; Morris J G; Tacket C O; Kaper J B; Levine M M
Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.
Clinical and diagnostic laboratory immunology 1997;4(3):264-9.
1997: Levine M M; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
Behring Institute Mitteilungen 1997;(98):120-3.
1997: Tacket C O; Sztein M B; Losonsky G A; Wasserman S S; Nataro J P; Edelman R; Pickard D; Dougan G; Chatfield S N; Levine M M
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.
Infection and immunity 1997;65(2):452-6.
1996: Morris J G; Sztein M B; Rice E W; Nataro J P; Losonsky G A; Panigrahi P; Tacket C O; Johnson J A
Vibrio cholerae O1 can assume a chlorine-resistant rugose survival form that is virulent for humans.
The Journal of infectious diseases 1996;174(6):1364-8.
1996: Silva T M; Schleupner M A; Tacket C O; Steiner T S; Kaper J B; Edelman R; Guerrant R
New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae.
Infection and immunity 1996;64(6):2362-4.
1996: Levine M M; Galen J; Barry E; Noriega F; Chatfield S; Sztein M; Dougan G; Tacket C
Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.
Journal of biotechnology 1996;44(1-3):193-6.
1995: Tacket C O; Losonsky G; Nataro J P; Comstock L; Michalski J; Edelman R; Kaper J B; Levine M M
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge.
The Journal of infectious diseases 1995;172(3):883-6.
1995: Morris J G; Losonsky G E; Johnson J A; Tacket C O; Nataro J P; Panigrahi P; Levin M M
Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.
The Journal of infectious diseases 1995;171(4):903-8.
1995: Nataro J P; Deng Y; Cookson S; Cravioto A; Savarino S J; Guers L D; Levine M M; Tacket C O
Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers.
The Journal of infectious diseases 1995;171(2):465-8.
1995: Tacket C O; Losonsky G; Nataro J P; Wasserman S S; Cryz S J; Edelman R; Levine M M
Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1995;89(1):75-7.
1995: Cryz S J; Kaper J; Tacket C; Nataro J; Levine M M
Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects.
Developments in biological standardization 1995;84():237-44.
1994: Sztein M B; Wasserman S S; Tacket C O; Edelman R; Hone D; Lindberg A A; Levine M M
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.
The Journal of infectious diseases 1994;170(6):1508-17.
1994: Edelman R; Tacket C O; Wasserman S S; Vaughn D W; Eckels K H; Dubois D R; Summers P L; Hoke C H
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.
The Journal of infectious diseases 1994;170(6):1448-55.
1994: Mackowiak P A; Wasserman S S; Tacket C O; Vaughn D W; Eckels K H; Dubois D R; Hoke C H; Edelman R
Quantitative relationship between oral temperature and severity of illness following inoculation with candidate attenuated dengue virus vaccines.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(5):948-50.
1994: Tacket C O; Reid R H; Boedeker E C; Losonsky G; Nataro J P; Bhagat H; Edelman R
Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres.
Vaccine 1994;12(14):1270-4.
1994: Wasserman S S; Losonsky G A; Noriega F; Tacket C O; Castañeda E; Levine M M
Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
Vaccine 1994;12(11):1000-3.
1994: Gonzalez C; Hone D; Noriega F R; Tacket C O; Davis J R; Losonsky G; Nataro J P; Hoffman S; Malik A; Nardin E
Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.
The Journal of infectious diseases 1994;169(4):927-31.
1994: Curtiss R; Kelly S M; Tinge S A; Tacket C O; Levine M M; Srinivasan J; Koopman M
Recombinant Salmonella vectors in vaccine development.
Developments in biological standardization 1994;82():23-33.
1993: Tacket C O; Losonsky G; Nataro J P; Cryz S J; Edelman R; Fasano A; Michalski J; Kaper J B; Levine M M
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.
The Journal of infectious diseases 1993;168(6):1536-40.
1993: Green S; Kurane I; Edelman R; Tacket C O; Eckels K H; Vaughn D W; Hoke C H; Ennis F A
Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination.
Journal of virology 1993;67(10):5962-7.
1993: Donnenberg M S; Tacket C O; James S P; Losonsky G; Nataro J P; Wasserman S S; Kaper J B; Levine M M
Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.
The Journal of clinical investigation 1993;92(3):1412-7.
1993: Losonsky G A; Tacket C O; Wasserman S S; Kaper J B; Levine M M
Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
Infection and immunity 1993;61(2):729-33.
1993: Keiser P; Fernie B; Tacket C; Wecksler W; Keay S
Anti-CD4 antibodies generated in response to HIV-1 rgp160 immunization of HIV-1-infected chimpanzees.
AIDS (London, England) 1993;7(1):136-8.
1993: Zivny J; Kurane I; Tacket C O; Edelman R; Ennis F A
Dengue virus-specific, human CD4+ cytotoxic T lymphocytes generated in short-term culture.
Viral immunology 1993;6(2):143-51.
1993: Edelman R; Russell R G; Losonsky G; Tall B D; Tacket C O; Levine M M; Lewis D H
Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide).
Vaccine 1993;11(2):155-8.
1992: Tacket C O; Losonsky G; Nataro J P; Cryz S J; Edelman R; Kaper J B; Levine M M
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.
The Journal of infectious diseases 1992;166(4):837-41.
1992: Tacket C O; Binion S B; Bostwick E; Losonsky G; Roy M J; Edelman R
Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge.
The American journal of tropical medicine and hygiene 1992;47(3):276-83.
1992: Hone D M; Tacket C O; Harris A M; Kay B; Losonsky G; Levine M M
Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.
The Journal of clinical investigation 1992;90(2):412-20.
1992: Clerici M; Berzofsky J A; Shearer G M; Giorgi J V; Tacket C
HIV-1 from a seronegative transplant donor.
The New England journal of medicine 1992;327(8):564-5.
1992: Morris J G; Tacket C O; Levine M M
Oral carrier vaccines: new tricks in an old trade.
Gastroenterology 1992;103(2):699-702.
1992: Keay S; Tacket C O; Murphy J R; Handwerger B S
Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1.
AIDS research and human retroviruses 1992;8(6):1091-8.
1992: Tacket C O; Hone D M; Curtiss R; Kelly S M; Losonsky G; Guers L; Harris A M; Edelman R; Levine M M
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.
Infection and immunity 1992;60(2):536-41.
1992: Tacket C O; Hone D M; Losonsky G A; Guers L; Edelman R; Levine M M
Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.
Vaccine 1992;10(7):443-6.
1992: Tacket C O; Clemens J; Kaper J B
Cholera vaccines.
Biotechnology (Reading, Mass.) 1992;20():53-68.
1992: Tacket C O; Losonsky G; Lubeck M D; Davis A R; Mizutani S; Horwith G; Hung P; Edelman R; Levine M M
Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine.
Vaccine 1992;10(10):673-6.
1991: Kotloff K L; Tacket C O; Wasserman S S; Bridwell M W; Cowan J E; Clemens J D; Brothers T A; O'Donnell S A; Quinn T C
A voluntary serosurvey and behavioral risk assessment for human immunodeficiency virus infection among college students.
Sexually transmitted diseases 1991;18(4):223-7.
1991: Clerici M; Berzofsky J A; Shearer G M; Tacket C O
Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]
The Journal of infectious diseases 1991;164(1):178-82.
1991: Clerici M; Tacket C O; Via C S; Lucey D R; Muluk S C; Zajac R A; Boswell R N; Berzofsky J A; Shearer G M
Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection.
European journal of immunology 1991;21(6):1345-9.
1991: Tacket C O; Losonsky G; Taylor D N; Baron L S; Kopecko D; Cryz S; Levine M M
Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
The Journal of infectious diseases 1991;163(4):901-4.
1991: Dolin R; Graham B S; Greenberg S B; Tacket C O; Belshe R B; Midthun K; Clements M L; Gorse G J; Horgan B W; Atmar R L
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.
Annals of internal medicine 1991;114(2):119-27.
1991: Kotloff K L; Tacket C O; Clemens J D; Wasserman S S; Cowan J E; Bridwell M W; Quinn T C
Assessment of the prevalence and risk factors for human immunodeficiency virus type 1 (HIV-1) infection among college students using three survey methods.
American journal of epidemiology 1991;133(1):2-8.
1990: Levine M M; Hone D; Tacket C; Ferreccio C; Cryz S
Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.
Research in microbiology 1990;141(7-8):807-16.
1990: Tacket C O; Moseley S L; Kay B; Losonsky G; Levine M M
Challenge studies in volunteers using Escherichia coli strains with diffuse adherence to HEp-2 cells.
The Journal of infectious diseases 1990;162(2):550-2.
1990: Nord J; Ma P; DiJohn D; Tzipori S; Tacket C O
Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients.
AIDS (London, England) 1990;4(6):581-4.
1990: Tacket C O; Forrest B; Morona R; Attridge S R; LaBrooy J; Tall B D; Reymann M; Rowley D; Levine M M
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.
Infection and immunity 1990;58(6):1620-7.
1990: Tacket C O; Baqar S; Munoz C; Murphy J R
Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant gp160.
AIDS research and human retroviruses 1990;6(4):535-42.
1990: Tacket C O; Edelman R
Ethical issues involving volunteers in AIDS vaccine trials.
The Journal of infectious diseases 1990;161(2):356.
1990: Archibald D W; Hebert C A; Sun D; Tacket C O
Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial.
Journal of acquired immune deficiency syndromes 1990;3(10):954-8.
1990: Edelman R; Tacket C O
Adjuvants.
International reviews of immunology 1990;7(1):51-66.
1989: Levine M M; Ferreccio C; Black R E; Tacket C O; Germanier R
Progress in vaccines against typhoid fever.
Reviews of infectious diseases 1989;11 Suppl 3():S552-67.
1989: Tacket C O
Molecular epidemiology of salmonella.
Epidemiologic reviews 1989;11():99-108.
1988: Levine M M; Kaper J B; Herrington D; Losonsky G; Tacket C; Tall B
The current status of cholera vaccine development and experience with cholera vaccine trials in volunteers.
The Southeast Asian journal of tropical medicine and public health 1988;19(3):401-15.
1988: Levine M M; Tacket C O; Herrington D; Losonsky G; Murphy J; Ferreccio C
The current status of typhoid vaccine development and clinical trials with typhoid vaccines.
The Southeast Asian journal of tropical medicine and public health 1988;19(3):459-69.
1988: Tacket C O; Levine M M; Robbins J B
Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
Vaccine 1988;6(4):307-8.
1988: Levine M M; Kaper J B; Herrington D; Ketley J; Losonsky G; Tacket C O; Tall B; Cryz S
Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.
Lancet 1988;2(8609):467-70.
1988: Tacket C O; Losonsky G; Link H; Hoang Y; Guesry P; Hilpert H; Levine M M
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.
The New England journal of medicine 1988;318(19):1240-3.
1987: Tacket C O; Maneval D R; Levine M M
Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159:H4.
Infection and immunity 1987;55(5):1063-9.
1987: Karch H; Heesemann J; Laufs R; O'Brien A D; Tacket C O; Levine M M
A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells.
Infection and immunity 1987;55(2):455-61.
1986: Tacket C O; Ferreccio C; Robbins J B; Tsai C M; Schulz D; Cadoz M; Goudeau A; Levine M M
Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
The Journal of infectious diseases 1986;154(2):342-5.
1986: Levine M M; Losonsky G; Herrington D; Kaper J B; Tacket C; Rennels M B; Morris J G
Pediatric diarrhea: the challenge of prevention.
Pediatric infectious disease 1986;5(1 Suppl):S29-43.
1985: Tacket C O; Ballard J; Harris N; Allard J; Nolan C; Quan T; Cohen M L
An outbreak of Yersinia enterocolitica infections caused by contaminated tofu (soybean curd).
American journal of epidemiology 1985;121(5):705-11.
1985: Tacket C O; Dominguez L B; Fisher H J; Cohen M L
An outbreak of multiple-drug-resistant Salmonella enteritis from raw milk.
JAMA : the journal of the American Medical Association 1985;253(14):2058-60.
1984: Tacket C O; Shahid N; Huq M I; Alim A R; Cohen M L
Usefulness of plasmid profiles for differentiation of Shigella isolates in Bangladesh.
Journal of clinical microbiology 1984;20(2):300-1.
1984: Tacket C O; Shandera W X; Mann J M; Hargrett N T; Blake P A
Equine antitoxin use and other factors that predict outcome in type A foodborne botulism.
The American journal of medicine 1984;76(5):794-8.
1984: Tacket C O; Brenner F; Blake P A
Clinical features and an epidemiological study of Vibrio vulnificus infections.
The Journal of infectious diseases 1984;149(4):558-61.
1984: Tacket C O; Barrett T J; Mann J M; Roberts M A; Blake P A
Wound infections caused by Vibrio vulnificus, a marine vibrio, in inland areas of the United States.
Journal of clinical microbiology 1984;19(2):197-9.
1984: Tacket C O; Narain J P; Sattin R; Lofgren J P; Konigsberg C; Rendtorff R C; Rausa A; Davis B R; Cohen M L
A multistate outbreak of infections caused by Yersinia enterocolitica transmitted by pasteurized milk.
JAMA : the journal of the American Medical Association 1984;251(4):483-6.
1983: Tacket C O; Davis B R; Carter G P; Randolph J F; Cohen M L
Yersinia enterocolitica pharyngitis.
Annals of internal medicine 1983;99(1):40-2.
1983: Hughes J M; Tacket C O
'Sausage poisoning' revisited.
Archives of internal medicine 1983;143(3):425-7.
1983: Tacket C O; Cohen M L
Shigellosis in day care centers: use of plasmid analysis to assess control measures.
Pediatric infectious disease 1983;2(2):127-30.
1983: Shandera W X; Tacket C O; Blake P A
Food poisoning due to Clostridium perfringens in the United States.
The Journal of infectious diseases 1983;147(1):167-70.
1982: Tacket C O
Vibrio cholerae infections.
JAMA : the journal of the American Medical Association 1982;248(22):2972.
1982: Tacket C O; Hickman F; Pierce G V; Mendoza L F
Diarrhea associated with Vibrio fluvialis in the United States.
Journal of clinical microbiology 1982;16(5):991-2.
1982: Tacket C O; Barrett T J; Sanders G E; Blake P A
Panophthalmitis caused by Vibrio parahaemolyticus.
Journal of clinical microbiology 1982;16(1):195-6.
1982: Morris J G; Miller H G; Wilson R; Tacket C O; Hollis D G; Hickman F W; Weaver R E; Blake P A
Illness caused by Vibrio damsela and Vibrio hollisae.
Lancet 1982;1(8284):1294-7.

Sign-in to see more